Navigation Links
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
Date:1/14/2014

ssays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Statements made in this release that express Luminex Corporation's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements. Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acceptance of Luminex's products, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable sales cycle and
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation Reports Third Quarter 2013 Results
2. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
3. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
4. Luminex Corporation Reports Second Quarter 2013 Results
5. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
6. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
7. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
8. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
9. Luminex Corporation To Present At Upcoming Investment Conferences
10. Luminex Corporation Reports First Quarter 2013 Results
11. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 About Duchenne muscular dystrophy ... generally affects the male population. It is characterized ... is caused due to mutations in the dystrophin ... of dystrophin (a protein essential for maintaining healthy ... weakens muscle function, causes loss of ambulation, harms ...
(Date:9/2/2015)... , Sept. 2, 2015 About Chronic Lymphocytic ... malignant condition characterized by increased production of lymphocytes. It ... and then it can spread to other parts of ... stages because of the slow buildup of the cancerous ... spreads to the spleen, liver, and lymph nodes. The ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... , ... (OTC Bulletin Board: HFGB), a leading developer and producer,of plant ... food production in Xi,an, China, today reported that in its,third ... Revenues for the quarter ended Sept. ...
... , NORTH HOLLYWOOD, Calif., Nov. ... a leading national hospitalist physician group practice company, announced today that ... ACP Hospitalist as one of the 2009 Top Ten Hospitalists ... of the magazine. , Dr. Vaidyan has been a practicing physician ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, ... of Atlanta to help support childhood cancer research. On June 17, 2014, ... Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... interim clinical staffing companies, has completed a recapitalization with new investment partners ... BPOC and Heritage Group each offer extensive expertise and connections within the ...
(Date:9/2/2015)... ... ... Every year at this time, students prepare to go back to school. Some ... academic workload confronting them. They just don’t have the skills needed to do their ... how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job of a ...
(Date:9/2/2015)... ... , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) sheds light ... on consumers. It was reported that 33% are paying an average of $39 more ... extra $100 compared to last year. Among the drugs that saw the highest increases ...
(Date:9/2/2015)... ... September 02, 2015 , ... World Patent Marketing, a vertically ... safety invention that protects people from crime and other hostile situations. , "The ... CEO and Creative Director of World Patent Marketing. "The industry is growing at ...
Breaking Medicine News(10 mins):Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... , TUESDAY, Dec. 6 (HealthDay News) -- Different molecular mechanisms ... aging of the reproductive system, new research with worms suggests. ... begins to decline after age 35 but other cells in ... later, study author Coleen Murphy of Princeton University said in ...
... (HealthDay News) -- Low levels of vitamin D are much ... obese and are associated with insulin resistance, a risk factor ... included 411 obese children and 87 children who weren,t overweight. ... serum insulin, body mass index and blood pressure. The ...
... rise and 48 percent of all breast cancers occur in ... to have breast reconstruction. A new study from Wake ... after mastectomy is safe for older women. The answer is ... the psychological, social and sexual well-being of the patient, establishing ...
... center and Universit Laval have discovered the likely cause ... more than 10 million North Americans. The team,s promising ... scientific journal Brain . Frequently confused with ... disorder. An estimated 4% of the population over 40 ...
... first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, ... Center New Orleans, reports that a significant number of ... and what factors contribute. The research is published online ... 5, 2011 Early Release section. The research team, which ...
... ( Marmota marmota ) live in extended family groups ... of a dominant territorial pair and a number of ... Over a 14-year period, Klaus Hacklnder of the Institute ... Resources and Life Sciences, Vienna and Walter Arnold of ...
Cached Medicine News:Health News:Research With Worms May Shed Light on Women's Fertility 2Health News:Vitamin D Levels Tied to Diabetes Risk in Obese Kids 2Health News:Advanced age should not deter women from breast reconstruction after cancer 2Health News:LSUHSC research finds many women not receiving recommended breast cancer adjuvant treatment 2Health News:LSUHSC research finds many women not receiving recommended breast cancer adjuvant treatment 3Health News:Hanging with the boys - female Alpine marmots benefit from a bit of pre-natal testosterone 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: